| Trial ID: | L0761 |
| Source ID: | NCT00677534
|
| Associated Drug: |
Cholecalciferol
|
| Title: |
Role of Extrarenal 1-Alpha-Hydroxylase in Patients With End Stage Renal Disease
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00677534/results
|
| Conditions: |
End-Stage Renal Disease
|
| Interventions: |
DRUG: Cholecalciferol
|
| Outcome Measures: |
Primary: Change in Monocyte VDR Expression With Vitamin D Therapy, Monocytes will be analyzed pre- and post-cholecalciferol by flow cytometry to measure changes in monocyte VDR expression. Unit of measure is represented by mean florescence intensity (MFI), which is a relative measure., Change from End of Washout to Week 12 |
|
| Sponsor/Collaborators: |
Sponsor: University of Kansas
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
7
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-05
|
| Completion Date: |
2009-08
|
| Results First Posted: |
2014-03-21
|
| Last Update Posted: |
2014-04-29
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00677534
|
